1 / 26

The clinical role of PET scanning in a consecutive series of GIST patients

The clinical role of PET scanning in a consecutive series of GIST patients. Frits van Coevorden & Lester van Ravenswade. Department of Surgery Netherlands Cancer Institute - Antoni van Leeuwenhoek ziekenhuis Amsterdam The Netherlands.

shawna
Télécharger la présentation

The clinical role of PET scanning in a consecutive series of GIST patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The clinical role of PET scanning in a consecutive series of GIST patients Frits van Coevorden & Lester van Ravenswade Department of Surgery Netherlands Cancer Institute - Antoni van Leeuwenhoek ziekenhuis Amsterdam The Netherlands

  2. The metabolic activity in GastroIntestinal Stromal Tumors has become of interest in this era of targeted therapy • Positron Emission Tomography is the imaging modality to assess metabolic activity in tumors

  3. The metabolic activity in GastroIntestinal Stromal Tumors has become of interest in this new Imatinib era • Positron Emission Tomography is the imaging modality to assess metabolic activity in tumors • PET imaging may reveal the metastatic character of tumors • Comparing PET activity before and after the start of TKI’s may provide useful information in assessing the response to drug treatment

  4. In a consecutive series of 98 evaluable patients seen in the Netherlands Cancer Institute between 2000 – 2007 our GIST database was reviewed with focus on the use of PET scanning • The indication for PET imaging was classified as: • Diagnostic to evaluate the primary tumor • Diagnostic to evaluate metastatic disease

  5. In a consecutive series of 98 evaluable patients seen in the Netherlands Cancer Institute between 2000 – 2007 our GIST database was reviewed with focus on the use of PET scanning • The indication for PET imaging was classified as: • Diagnostic to evaluate a primary tumor • Diagnostic to evaluate metastatic disease • Diagnostic tool to prove or exclude recurrent or residual disease after previous surgery • Response assessment of drug treatment

  6. Methods • We reviewed all files and PET -CT studies • Classified PET imaging as: • diagnostic only • diagnostic and used for response evaluation

  7. Methods • We reviewed all files and PET -CT studies • Classified PET imaging as: • diagnostic only • diagnostic and used for response evaluation • Correlated the outcome to the associated CT scan • Classified the comparison results as: • Conformal or Discrepant

  8. Methods • We reviewed all files and PET -CT studies • Classified PET imaging as: • diagnostic only • diagnostic and used for response evaluation • Correlated the outcome to the associated CT scan • Classified the comparison results as: • Conformal or Discrepant • Correlated the results to the clinical course of the patient with follow up

  9. Results (1) • the data here presented are an update of those in abstract 934 • 98 evaluable patients • 45 patients had one or more PET scans • 4 scans as tool to search for residual or possible recurrent disease after surgery: • All were negative, as was the clinical and CT correlate • In 41 patients PET was supposed to show activity

  10. Results (2) • PET was false negative in 9 /45 patients (20 %) • 3 in active primary or local recurrent disease • 6 in metastatic hepatic or peritoneal disease

  11. Results (2) • PET was false negative in 9 /45 patients (20 %) • 3 in active primary or local recurrent disease • 45 yr female 6 cm bilobar endogastric Gist

  12. Results (2) • PET was false negative in 9 /45 patients (20%) • 3 in active primary or local recurrent disease • 51 yr male 10 cm small curvature gastric Gist 50% vital after 1 yr Imatinib

  13. Results (3) • PET was false negative in 9 /45 patients (20 %) • PET was true negative in 4 patients (post surgery controls) • PET was true positive in 32 patients • …. so 80 % correlation to CT scan and Clinic !!

  14. Results (3) • PET was false negative in 9 /45 patients (20 %) • PET was true negative in 4 patients (post surgery controls) • PET was true positive in 32 patients • Repeat PET used for response assessment in 23 patients

  15. Results (4) • Repeat PET for response assessment in 23 patients • 19 patients PET confirmed good response • 3 unchanged PET activity confirmed active SD on CT • …. so if 1st PET shows disease activity • 95 % correlation to CT scan and Clinic !!

  16. Results (4) • Repeat PET for response assessment in 23 patients • 19 patients confirmed good response • 3 unchanged PET activity confirmed active SD on CT • 1 discrepancy

  17. Case presented at CTOS 2006 in Venice • 33 yr male • dec 2005 resection of high grade small bowel GIST • randomized in 62024 to control group

  18. Case presented at CTOS 2006 in Venice • 33 yr male • dec 2005 resection of high grade small bowel GIST • randomized in 62024 to control group • aug 2006: peritoneal recurrence • Start Imatinib 400 mg

  19. Case presented at CTOS 2006 in Venice

  20. After Glivec After Glivec August 2006: Start (neoadjuvant)Imatinib 400 mg October 2006: effect ??? Before Glivec Or response ? Progression ? So he went for surgery

  21. After Glivec After Glivec Bad message: At pathology the PET negative tumor more than 90% vital GIST Before Glivec

  22. Bad message: At pathology the PET negative tumor more than 90% vital GIST Good message: Exon 9 mutation Now 1 year later on 800 mg Imatinib: NO ACTIVE DISEASE So maybe PET did predict a favourable outcome very early ??

  23. Survival related to PET scanning

  24. PET response correlated to outcome at FU

  25. Conclusions • PET had a 80 % correlation to active GIST • but PET was false negative in 20 % • If PET is positive: 95% correct response correlation • No change or PD at response assessment predicts a poor outcome

  26. Thank you

More Related